Cash and Short Term Investments (Annual) Chart

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 139.34M
December 31, 2024 209.54M
December 31, 2023 328.83M
December 31, 2022 247.66M
Date Value
December 31, 2021 375.83M
December 31, 2020 15.95M
December 31, 2019 41.07M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Anavex Life Sciences Corp. 102.58M
Intellia Therapeutics, Inc. 449.88M
Vir Biotechnology, Inc. 468.94M
Vaxcyte, Inc. 1.561B
Foghorn Therapeutics, Inc. 160.14M